Atrás
27
Rango del Día
$48.27
$61.39
Rango de 52 Semanas
$46.06
$61.39
Volumen
500
Promedio 50D / 200D
$48.27
/
$46.91
Cierre Anterior
$48.27
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 0.1 | 0.3 |
| P/B | 0.0 | 3.0 |
| ROE % | 12.7 | 3.7 |
| Net Margin % | 3.1 | 3.8 |
| Rev Growth 5Y % | 8.6 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$527.59
$518.46 – $539.59
|
1.40T | 1 |
| FY2029 |
$503.41
$494.70 – $514.87
|
1.32T | 1 |
| FY2028 |
$444.78
$437.09 – $454.90
|
1.21T | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-13 | $98.32 | $0.52 | -99.5% |
| 2025-10-14 | $0.76 | $0.70 | -8.0% |
| 2025-07-10 | $0.78 | $0.76 | -2.8% |
| 2025-04-14 | $0.51 | $0.66 | +30.6% |
| 2025-01-10 | $0.43 | $0.53 | +24.0% |
| 2024-10-11 | $0.61 | $0.70 | +15.8% |
| 2024-07-12 | $0.61 | $0.57 | -7.2% |
| 2024-04-12 | $0.45 | $0.97 | +114.1% |
Dividend History
Yield
0.01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 29, 2026 | Aug 01, 2026 | $0.25 | 1.03% |
| Nov 28, 2025 | Feb 12, 2026 | $0.24 | 1.09% |
| May 30, 2025 | Aug 04, 2025 | $0.26 | 1.03% |
| Nov 29, 2024 | Feb 12, 2025 | $0.21 | 1.03% |
| May 31, 2024 | Aug 01, 2024 | $0.38 | 0.80% |
| Nov 29, 2023 | Feb 13, 2024 | $0.41 | 0.83% |
| May 30, 2023 | Aug 03, 2023 | $0.41 | 0.73% |
| Nov 29, 2022 | Feb 13, 2023 | $0.31 | 0.63% |
| May 30, 2022 | Aug 24, 2022 | $0.31 | 0.68% |
| Nov 29, 2021 | Feb 14, 2022 | $0.35 | 0.75% |
| May 28, 2021 | Aug 25, 2021 | $0.39 | 0.66% |
| Nov 27, 2020 | Feb 12, 2021 | $0.26 | 0.55% |
| May 28, 2020 | Aug 24, 2020 | $0.56 | 0.52% |
| Nov 28, 2019 | Feb 13, 2020 | $0.46 | 0.49% |
| May 29, 2019 | Aug 26, 2019 | $0.41 | 0.46% |
| Nov 28, 2018 | Feb 13, 2019 | $0.39 | 0.41% |
| May 29, 2018 | Aug 27, 2018 | $0.41 | 0.42% |
| Nov 28, 2017 | Feb 14, 2018 | $0.40 | 0.62% |
| May 29, 2017 | Aug 28, 2017 | $0.40 | 0.41% |
| May 27, 2016 | Aug 26, 2016 | $0.32 | 0.16% |
Puntos Clave
Revenue grew 8.63% annually over 5 years — modest growth
Earnings grew 26.68% over the past year
ROE of 12.67% — decent returns on equity
Debt/Equity of 0.19 — conservative balance sheet
Negative free cash flow of -859.00M
P/E of 0.12 — trading at a low valuation
Crecimiento
Revenue Growth (5Y)
8.63%
Revenue (1Y)4.81%
Earnings (1Y)26.68%
FCF Growth (3Y)N/A
Calidad
Return on Equity
12.67%
ROIC9.86%
Net Margin3.06%
Op. Margin3.99%
Seguridad
Debt / Equity
0.19
Current Ratio0.75
Interest Coverage159.07
Valoración
P/E Ratio
0.12
Forward P/EN/A
P/B Ratio0.01
EV/EBITDA-0.08
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.81% | Revenue Growth (3Y) | 10.54% |
| Earnings Growth (1Y) | 26.68% | Earnings Growth (3Y) | 14.09% |
| Revenue Growth (5Y) | 8.63% | Earnings Growth (5Y) | 3.35% |
| Profitability | |||
| Revenue (TTM) | 1.01T | Net Income (TTM) | 30.98B |
| ROE | 12.67% | ROA | 5.90% |
| Gross Margin | 21.09% | Operating Margin | 3.99% |
| Net Margin | 3.06% | Free Cash Flow (TTM) | -859.00M |
| ROIC | 9.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.19 | Current Ratio | 0.75 |
| Interest Coverage | 159.07 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0.12 | Forward P/E | N/A |
| P/B Ratio | 0.01 | P/S Ratio | 0.00 |
| PEG Ratio | 0.63 | Forward PEG | N/A |
| EV/EBITDA | -0.08 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -22.45% | ||
| Market Cap | 3.83B | Enterprise Value | -3.26B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.01T | 964.99B | 827.70B | 755.41B | 726.42B |
| Net Income | 30.98B | 24.45B | 23.80B | 23.16B | 27.16B |
| EPS (Diluted) | 390.86 | 308.61 | 600.95 | 584.74 | 685.77 |
| Gross Profit | 213.28B | 188.31B | 168.72B | 151.45B | 145.11B |
| Operating Income | 40.40B | 31.50B | 30.13B | 29.80B | 33.15B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 524.76B | 476.55B | 420.97B | 363.05B | 341.32B |
| Total Liabilities | 267.29B | 245.11B | 209.90B | 172.55B | 170.74B |
| Shareholders' Equity | 257.46B | 231.44B | 211.07B | 190.51B | 170.58B |
| Total Debt | 49.96B | 34.06B | 18.20B | 9.41B | 10.44B |
| Cash & Equivalents | 57.04B | 52.30B | 45.93B | 37.36B | 55.11B |
| Current Assets | 165.62B | 154.33B | 137.09B | 115.47B | 125.13B |
| Current Liabilities | 220.68B | 213.23B | 192.05B | 162.06B | 159.54B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#375 of 709
Actividad Reciente
Entró
Defensive Investing (Benjamin Graham)
Mar 24, 2026